Activity of teicoplanin in localized experimental infections in rats
- PMID: 2871103
- DOI: 10.1016/0195-6701(86)90013-7
Activity of teicoplanin in localized experimental infections in rats
Abstract
We tested the ability of teicoplanin alone and in combination with rifampicin or gentamicin to cure experimental endocarditis and granuloma pouch infections in rats caused by Streptococcus faecalis, Str. sanguis, methicillin-sensitive and -resistant Staphylococcus aureus. Vancomycin and ampicillin were also tested. Teicoplanin was more active than vancomycin and ampicillin. Combinations of teicoplanin with rifampicin or gentamicin were significantly more effective than single drug therapy. These results suggest that teicoplanin could be an interesting alternative to vancomycin in the treatment of serious streptococcal and staphylococcal infections in man.
Similar articles
-
Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.J Infect Dis. 1986 Jul;154(1):69-75. doi: 10.1093/infdis/154.1.69. J Infect Dis. 1986. PMID: 2940303
-
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.Antimicrob Agents Chemother. 1984 Jul;26(1):61-4. doi: 10.1128/AAC.26.1.61. Antimicrob Agents Chemother. 1984. PMID: 6236747 Free PMC article.
-
[Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].Enferm Infecc Microbiol Clin. 1991 Apr;9(4):208-10. Enferm Infecc Microbiol Clin. 1991. PMID: 1830757 Spanish.
-
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.J Antimicrob Chemother. 1986 Mar;17 Suppl A:19-24. doi: 10.1093/jac/17.suppl_a.19. J Antimicrob Chemother. 1986. PMID: 2940212 Review.
-
Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations.J Antimicrob Chemother. 1988 Apr;21 Suppl C:91-106. doi: 10.1093/jac/21.suppl_c.91. J Antimicrob Chemother. 1988. PMID: 3290187 Review.
Cited by
-
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.Antimicrob Agents Chemother. 1990 May;34(5):827-30. doi: 10.1128/AAC.34.5.827. Antimicrob Agents Chemother. 1990. PMID: 2141778 Free PMC article.
-
Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia.Clin Drug Investig. 1996 Aug;12(2):80-7. doi: 10.2165/00044011-199612020-00003. Clin Drug Investig. 1996. PMID: 24610668
-
Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections.Antimicrob Agents Chemother. 1992 Feb;36(2):446-52. doi: 10.1128/AAC.36.2.446. Antimicrob Agents Chemother. 1992. PMID: 1534978 Free PMC article.
-
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 1994 Aug;38(8):1703-10. doi: 10.1128/AAC.38.8.1703. Antimicrob Agents Chemother. 1994. PMID: 7985998 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical